Bhubaneswar: At a time when many in the country find it difficult to afford paying for cancer treatment, a woman entrepreneur Dr Nusrat Sanghamitra from Balasore district of Odisha has taken a great step forward in medical science bringing a ray of hope for cancer patients.
Sanghamitra has established an Indo-Irish Biotech startup CyGenica (formerly CyCa OncoSolutions) at Pune. The company is committed to bring the best innovation in health care for cancer patients. She is the Founder, Chief Executive Officer (CEO), and Chief Strategy Officer (CSO) of the startup.
She started her research journey with a mission ‘to find a better anticancer drug with fewer side effects’. Her startup focuses on technology to sharply bring down the economic and social cost of managing cancer and improve the quality of life for nearly 15 million cancer patients across the globe.
Born at Kaji Mohalla in Soro of Balasore district, Sanghamitra was still a student when her father was diagnosed with cancer. She had witnessed her father suffering from the side effects of cancer treatment. This life experience defined the goal of her life ‘how to make cancer drugs safer and better’ to make an impact in oncology and do her bit in the global fight against cancer.
Sanghamitra wanted to be a doctor but unable to do so she completed her Post Graduation in Chemistry at Fakir Mohan Autonomous College, Balasore. She obtained her PhD from one of India’s premier research Institute Indian Institute of Science, Bangalore. After a Postdoctoral Fellowship in Leiden University, The Netherlands and Kyoto University, Japan she founded CyCa OncoSolutions (now CyGenica).
Her academic experience in the field of biofunctional chemistry spans over 17 years. Her research has been well cited. She received the Foresight Fellowship in Molecular Machines in 2018, and the National Award from the President of India for Technology Startup that same year.